Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 8484956)

Published in Biochem Med Metab Biol on April 01, 1993

Authors

R Musanti1, E Parati, E Lamperti, G Ghiselli

Author Affiliations

1: Farmitalia Carlo Erba Research Institute, Milan, Italy.

Articles by these authors

Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84

Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. J Neurol Neurosurg Psychiatry (1984) 1.22

Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest (1982) 1.20

Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol (2008) 1.18

Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol Metab (1983) 1.13

Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. J Acquir Immune Defic Syndr (2000) 1.11

Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ (2005) 1.10

The role of ultrasonography in blunt abdominal trauma: results in 250 consecutive cases. J Trauma (1994) 1.05

A prospective multicenter trial of excimer laser phototherapeutic keratectomy for corneal vision loss. The Summit Phototherapeutic Keratectomy Study Group. Am J Ophthalmol (1996) 1.05

Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest (2001) 1.02

Evidence that two synthetic pathways contribute to the apolipoprotein B pool of the low density lipoprotein fraction of rabbit plasma. Biochim Biophys Acta (1982) 1.01

Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res (1985) 1.01

Plasma metabolism of apolipoprotein A-IV in humans. J Lipid Res (1986) 0.99

Self-closing Nitinol U-Clips for intracranial arterial microanastomosis: a preliminary experience on seven cases. Acta Neurochir (Wien) (2009) 0.99

Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. Biochem Biophys Res Commun (1986) 0.98

Headache in brain tumours: a symptom to reappraise critically. Neurol Sci (2004) 0.97

The chemical characterization of melanin contained in substantia nigra of human brain. Biochim Biophys Acta (1992) 0.97

Human microvascular endothelial cells from different fetal organs demonstrate organ-specific CAM expression. Exp Cell Res (2005) 0.96

Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients. Lancet (1982) 0.93

Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain Res (1986) 0.89

Apolipoprotein A-I isoforms in human lymph: effect of fat absorption. J Lipid Res (1983) 0.89

Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I. J Lipid Res (1985) 0.88

Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report. Neurol Sci (2002) 0.88

Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience. J Neurooncol (2011) 0.86

Percutaneous ultrasound-guided drainage of intra-abdominal abscesses. Br J Surg (1993) 0.86

Cryptococcal meningoencephalitis: intrathecal immunological response. J Neurol (1986) 0.85

Typical and atypical forms of paroxysmal choreoathetosis. Dev Med Child Neurol (1989) 0.85

Safety of bevacizumab in patients with malignant gliomas: a systematic review. Neurol Sci (2013) 0.84

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience. J Neurooncol (2006) 0.83

Origin of apolipoprotein A-I polymorphism in plasma. J Biol Chem (1985) 0.82

Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I. Biochem Biophys Res Commun (1983) 0.82

Update on treatment strategies for anaplastic glioma: a review of literature. Neurol Sci (2014) 0.82

Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia. Atherosclerosis (1992) 0.81

Apolipoprotein A-I isoprotein synthesis by the perfused rat liver. Biochem Biophys Res Commun (1982) 0.80

Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol (1989) 0.80

Rechallenge with temozolomide in recurrent glioma. Neurol Sci (2011) 0.80

Heparin binding to human plasma low-density lipoproteins: dependence on heparin sulfation degree and chain length. Biochemistry (1992) 0.80

Tremor as an early manifestation of systemic lupus erythematosus. Clin Exp Rheumatol (1994) 0.79

Proapolipoprotein A-I conversion kinetics in vivo in human and in rat. Proc Natl Acad Sci U S A (1985) 0.79

Obliteration of a giant fusiform carotid terminus-M1 aneurysm after distal clip application and extracranial-intracranial bypass. Case report. J Neurosurg Sci (2007) 0.79

Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization. Cancer Immunol Immunother (2004) 0.79

Impaired cardiovascular reflexes in cluster headache and migraine patients: evidence for an autonomic dysfunction. Headache (1988) 0.78

Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity. Int J Immunopathol Pharmacol (2013) 0.78

Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. Atherosclerosis (1982) 0.78

IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings. Ital J Neurol Sci (1997) 0.78

FCE 27677: a novel inhibitor of acyl-CoA: cholesterol acyltransferase with potent oral hypolipidemic activity. Pharmacol Res (1995) 0.78

Lecture: fotemustine in brain tumors. Neurol Sci (2011) 0.78

Malignant gliomas: early diagnosis and clinical aspects. Neurol Sci (2011) 0.77

Effect of serum lipoproteins on the adenylate cyclase activity of rat liver plasma membranes. Biochem J (1981) 0.77

Plasma catabolism of human apolipoprotein E isoproteins: lack of conversion of the doubly sialylated form to the asialo form in plasma. Metabolism (1986) 0.77

Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol (1994) 0.77

Human neural progenitor cells display limited cytotoxicity and increased oligodendrogenesis during inflammation. Cell Death Differ (2006) 0.77

Local drug delivery in recurrent malignant gliomas. Neurol Sci (2005) 0.77

Idiopathic dystonia with onset in childhood. J Neurol (1989) 0.77

Pravastatin in vivo reduces mononuclear cell migration through endothelial monolayers. Neurol Sci (2006) 0.76

Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors. Neuropharmacology (1986) 0.76

Peritoneal macrophage cholesteryl ester content as a function of plasma cholesterol in rats. Arterioscler Thromb (1991) 0.76

Meningitis following relapsing painful ophthalmoplegia in aspergillus sphenoidal sinusitis: a case report. Neurol Sci (2006) 0.76

Neuro-oncological diagnosis in patients without histological confirmation. Neurol Sci (2011) 0.76

Venous thromboembolism in malignant glioma patients treated by chemoradiotherapy. Neurol Sci (2003) 0.76

Acute bucket-handle tear of the medial meniscus in a golfer. Arthroscopy (2001) 0.76

Brainstem auditory evoked potential (BAEPs) in cluster headache (CH): new aspects for a central theory. Headache (1986) 0.76

Genetics of cerebral hemorrhage and microbleeds. Panminerva Med (2013) 0.75

Infections in neuro-oncology. Neurol Sci (2011) 0.75

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience. J Neurooncol (2013) 0.75

Growth hormone and prolactin stimulation by Madopar in Parkinson's disease. J Neurol Neurosurg Psychiatry (1981) 0.75

New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM). J Exp Clin Cancer Res (2003) 0.75

2-dimethylaminoethanol (Deanol) in Huntington's chorea. J Neurol Neurosurg Psychiatry (1978) 0.75

Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. J Neurol Neurosurg Psychiatry (1977) 0.75

Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma. J Neurooncol (2005) 0.75

Short and medium-term influence of physical activity on immune parameters. Int J Neurosci (1993) 0.75

Radioimmunoassay of rat apolipoprotein A-IV. Anal Biochem (1986) 0.75

Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes. Monogr Neural Sci (1980) 0.75

[Ultrasonic diagnosis of gastroduodenal perforation]. Radiol Med (1992) 0.75

Decreased CSF levels of homovanillic acid in ALS patients. Eur J Neurol (1995) 0.75

Pupillometry and radioreceptor binding. Semeiologic suggestions in the evaluation of the treatment with anticholinergic drugs. Arzneimittelforschung (1990) 0.75

Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins. Biochim Biophys Acta (1984) 0.75

Effect of L-propranolol on the binding, Internalization and degradation of 125I-low density lipoproteins by human skin fibroblasts. Biochem Biophys Res Commun (1981) 0.75

Rapid modulation of rat adipocyte lipoprotein lipase: effect of calcium, A23187 ionophore, and thrombin. Biochim Biophys Acta (1989) 0.75

Problems arising during chronic treatment with L-dopa for Parkinson's disease: changes in response to treatment. J Neural Transm Suppl (1986) 0.75

Bromocriptine--lisuride cross tolerance. Ital J Neurol Sci (1983) 0.75

Bromocriptine and lisuride in Parkinson's disease. Adv Neurol (1984) 0.75

A comparative study of low-density lipoprotein interaction with glycosaminoglycans. Biochim Biophys Acta (1993) 0.75

Mediterranean-soy diet: hypocholesterolemic effects in FH E3/E2 heterozygous and type III patients. Riv Eur Sci Med Farmacol (1987) 0.75

Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol. Arterioscler Thromb (1993) 0.75

Proapolipoprotein A-I metabolism in the human and the rat. Adv Exp Med Biol (1985) 0.75

Enhanced macrophage uptake of elastase-modified high-density lipoproteins. Biochem Biophys Res Commun (2000) 0.75

Correction of dyslipoproteinaemia of casein-fed rabbit by FCE 27677, a potent novel ACAT inhibitor. Pharmacol Res (1996) 0.75

Physical effort-induced changes in immune parameters. Int J Neurosci (1993) 0.75

Intrasplenic posttraumatic pseudoaneurysm: echo color doppler diagnosis. J Trauma (1996) 0.75

Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors. J Enzyme Inhib (1994) 0.75

Dopamine receptor changes in response to prolonged treatment with L-dopa. J Neural Transm Suppl (1986) 0.75

"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine". Ital J Neurol Sci (1981) 0.75

Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line (bEnd.4). J Cardiovasc Risk (1995) 0.75

Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J Lipid Res (1996) 0.75

Role of physical training on immune function: preliminary data. Int J Neurosci (1990) 0.75

Cessation of migraine with aura following removal of left atrial myxoma. Eur J Neurol (2006) 0.75